Aurora Cannabis Holds 2024 Annual Meeting, Elects Directors

Ticker: ACB · Form: 6-K · Filed: Aug 12, 2024 · CIK: 1683541

Aurora Cannabis Inc 6-K Filing Summary
FieldDetail
CompanyAurora Cannabis Inc (ACB)
Form Type6-K
Filed DateAug 12, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: annual-meeting, corporate-governance, news-release

Related Tickers: ACB

TL;DR

Aurora Cannabis shareholders voted on directors and auditors at their 2024 annual meeting.

AI Summary

Aurora Cannabis Inc. announced the results of its 2024 Annual General and Special Meeting held on August 12, 2024. Key resolutions passed included the election of directors and the appointment of auditors. The company's CEO, Miguel Martin, signed off on the report.

Why It Matters

The meeting's outcomes are crucial for corporate governance, confirming the board of directors and auditor, which impacts investor confidence and operational oversight.

Risk Assessment

Risk Level: low — This filing is a routine update on the results of an annual general meeting and does not contain significant new financial or operational information.

Key Players & Entities

  • Aurora Cannabis Inc. (company) — Registrant
  • Miguel Martin (person) — Chief Executive Officer
  • August 12, 2024 (date) — Meeting Date

FAQ

What type of report is Aurora Cannabis Inc. filing?

Aurora Cannabis Inc. is filing a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.

When was the 2024 Annual General and Special Meeting held?

The 2024 Annual General and Special Meeting was held on August 12, 2024.

Who signed the Form 6-K report on behalf of Aurora Cannabis Inc.?

Miguel Martin, Chief Executive Officer, signed the report on behalf of Aurora Cannabis Inc.

What is the principal executive office address for Aurora Cannabis Inc.?

The principal executive office address is 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada.

What exhibit is submitted with this Form 6-K filing?

Exhibit 99.1, a News Release dated August 12, 2024, is submitted with this Form 6-K filing.

Filing Stats: 144 words · 1 min read · ~1 pages · Grade level 10.9 · Accepted 2024-08-12 13:54:03

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F Form 40-F SUBMITTED HEREWITH Exhibits Description 99.1 News Release dated August 12, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Miguel Martin Miguel Martin Chief Executive Officer Date: August 12, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.